373 related articles for article (PubMed ID: 18346773)
1. Intersexual variations in Northern (Missulena pruinosa) and Eastern (M. bradleyi) mouse spider venom.
Herzig V; Khalife AA; Chong Y; Isbister GK; Currie BJ; Churchill TB; Horner S; Escoubas P; Nicholson GM; Hodgson WC
Toxicon; 2008 Jun; 51(7):1167-77. PubMed ID: 18346773
[TBL] [Abstract][Full Text] [Related]
2. Isolation of delta-missulenatoxin-Mb1a, the major vertebrate-active spider delta-toxin from the venom of Missulena bradleyi (Actinopodidae).
Gunning SJ; Chong Y; Khalife AA; Hains PG; Broady KW; Nicholson GM
FEBS Lett; 2003 Nov; 554(1-2):211-8. PubMed ID: 14596942
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating.
Rash LD; Birinyi-Strachan LC; Nicholson GM; Hodgson WC
Br J Pharmacol; 2000 Aug; 130(8):1817-24. PubMed ID: 10952670
[TBL] [Abstract][Full Text] [Related]
4. Intersexual variations in the pharmacological properties of Coremiocnemis tropix (Araneae, Theraphosidae) spider venom.
Herzig V; Hodgson WC
Toxicon; 2009 Feb; 53(2):196-205. PubMed ID: 19046981
[TBL] [Abstract][Full Text] [Related]
5. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and high-performance liquid chromatography study of quantitative and qualitative variation in tarantula spider venoms.
Escoubas P; Corzo G; Whiteley BJ; Célérier ML; Nakajima T
Rapid Commun Mass Spectrom; 2002; 16(5):403-13. PubMed ID: 11857724
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxic and insecticidal properties of venom from the Australian theraphosid spider Selenotholus foelschei.
Herzig V; Hodgson WC
Neurotoxicology; 2008 May; 29(3):471-5. PubMed ID: 18423874
[TBL] [Abstract][Full Text] [Related]
7. The omega-atracotoxins: selective blockers of insect M-LVA and HVA calcium channels.
Chong Y; Hayes JL; Sollod B; Wen S; Wilson DT; Hains PG; Hodgson WC; Broady KW; King GF; Nicholson GM
Biochem Pharmacol; 2007 Aug; 74(4):623-38. PubMed ID: 17610847
[TBL] [Abstract][Full Text] [Related]
8. The in vitro neurotoxic and myotoxic effects of the venom from the Suta genus (curl snakes) of elapid snakes.
Kuruppu S; Robinson S; Hodgson WC; Fry BG
Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):407-10. PubMed ID: 18028104
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monomeric and multimeric snake neurotoxins and other bioactive proteins from the venom of the lethal Australian common copperhead (Austrelaps superbus).
Marcon F; Purtell L; Santos J; Hains PG; Escoubas P; Graudins A; Nicholson GM
Biochem Pharmacol; 2013 May; 85(10):1555-73. PubMed ID: 23500536
[TBL] [Abstract][Full Text] [Related]
10. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms.
Chetty N; Du A; Hodgson WC; Winkel K; Fry BG
Toxicon; 2004 Aug; 44(2):193-200. PubMed ID: 15246769
[TBL] [Abstract][Full Text] [Related]
11. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
[TBL] [Abstract][Full Text] [Related]
12. VdTX-1, a reversible nicotinic receptor antagonist isolated from venom of the spider Vitalius dubius (Theraphosidae).
Rocha-E-Silva TA; Rostelato-Ferreira S; Leite GB; da Silva PI; Hyslop S; Rodrigues-Simioni L
Toxicon; 2013 Aug; 70():135-41. PubMed ID: 23668938
[TBL] [Abstract][Full Text] [Related]
13. Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.
Graudins A; Padula M; Broady K; Nicholson GM
Ann Emerg Med; 2001 Feb; 37(2):154-60. PubMed ID: 11174232
[TBL] [Abstract][Full Text] [Related]
14. Cloning and activity of a novel α-latrotoxin from red-back spider venom.
Graudins A; Little MJ; Pineda SS; Hains PG; King GF; Broady KW; Nicholson GM
Biochem Pharmacol; 2012 Jan; 83(1):170-83. PubMed ID: 22001442
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular action of venom from the South American colubrid snake Philodryas patagoniensis.
Carreiro da Costa RS; Prudêncio L; Ferrari EF; Souza GH; de Mello SM; Prianti Júnior AC; Ribeiro W; Zamunér SR; Hyslop S; Cogo JC
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jul; 148(1):31-8. PubMed ID: 18455482
[TBL] [Abstract][Full Text] [Related]
16. Milking and partial characterization of venom from the Brazilian spider Vitalius dubius (Theraphosidae).
Rocha-E-Silva TA; Sutti R; Hyslop S
Toxicon; 2009 Jan; 53(1):153-61. PubMed ID: 19032960
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the heterotrimeric presynaptic phospholipase A(2) neurotoxin complex from the venom of the common death adder (Acanthophis antarcticus).
Blacklow B; Escoubas P; Nicholson GM
Biochem Pharmacol; 2010 Jul; 80(2):277-87. PubMed ID: 20361942
[TBL] [Abstract][Full Text] [Related]
18. Taxonomy of Australian Funnel-web spiders using rp-HPLC/ESI-MS profiling techniques.
Wilson D; Alewood PF
Toxicon; 2006 May; 47(6):614-27. PubMed ID: 16554080
[TBL] [Abstract][Full Text] [Related]
19. Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach.
Escoubas P; Sollod B; King GF
Toxicon; 2006 May; 47(6):650-63. PubMed ID: 16574177
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the complex venom landscapes of lethal Australian funnel-web spiders (Hexathelidae: Atracinae) using LC-MALDI-TOF mass spectrometry.
Palagi A; Koh JM; Leblanc M; Wilson D; Dutertre S; King GF; Nicholson GM; Escoubas P
J Proteomics; 2013 Mar; 80():292-310. PubMed ID: 23352897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
